DRKS00027120已完成不适用
Tirbanibulin 1% Ointment in field therapy for the treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis on the face or scalp in adults - KLIR – Klisyri® in real world treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 549
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •Any person who is at least 18 years old, has signed and dated this informed consent form and for whom treatment with Klisyri® 10 mg/g ointment has been planned by the treating physician may participate in this study.
排除标准
- •Patients who are not eligible for treatment with Klisyri® in accordance with the approved product information.
研究者
相似试验
已完成
2 期
Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites.AscitesPortal HypertensionDiuretic refractory ascitesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCirrhosisACTRN12616000321448Paul Gow5
招募中
2 期
CCH2201/MK013 trialJPRN-jRCT2031220529Wataru Munakata20
进行中(未招募)
1 期
Investigation of 0.1% tacrolimus ointment for the treatment of vitiligo patients - VitiligoEUCTR2005-002922-79-CZAvemedica, s.r.o.50
招募中
1 期
Multi-drug treatment for breast cancer patients with brain metastasesCTIS2024-510703-11-00nicancer55
已完成
2 期
The explorative clinical trial of a medicine for treatment of CIN (Cervical Intraepithelial Neoplasia) using lactobacillus to HPV16 positive CIN 2.Cervical Intraepithelial Neoplasia 2 (CIN2)JPRN-UMIN000012229The University of Tokyo Hospital Department of Obstetrics & Gynecology40
